Advertisement
Immune therapy scores big win against lung cancer in study

Immune therapy scores big win against lung cancer in study

By Associated Press  |  April 16, 2018

A treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success in less common cancers.

Delivering a jolt to spotlight a health crisis

Delivering a jolt to spotlight a health crisis

By David Royse  |  November 10, 2016

Inspired in part by the meth campaign, the hospital jolted parents—and stirred up plenty of criticism— with TV ads and billboards featuring pictures of overweight children, many with messages that subtly criticized parents. One, for example, said, “Big bones didn't make me this...

Some immune-boosting cancer drugs may pose rare heart risks

By Associated Press  |  November 03, 2016

Doctors have found a disturbing downside to some powerful new drugs that harness the immune system to fight cancer. In rare cases, they may cause potentially fatal heart damage, especially when used together.

Merck beats Q1 profit outlooks with tight cost controls

By Associated Press  |  May 05, 2016

Merck posted an 18% jump in first-quarter income, beating Wall Street expectations, as reduced spending on marketing, administration and research easily offset lower sales of its medicines outside the U.S.

Napster co-founder bankrolls project to speed cancer work

Napster co-founder bankrolls project to speed cancer work

By Associated Press  |  April 13, 2016

The newly created Parker Institute for Cancer Immunotherapy is being funded by a $250 million grant from Sean Parker, the co-founder of the file-sharing site Napster and Facebook's first president. It brings together partners at six top academic cancer centers, dozens of drugmakers and other groups.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print